1. Home
  2. RLAY vs TRS Comparison

RLAY vs TRS Comparison

Compare RLAY & TRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$8.29

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo TriMas Corporation

TRS

TriMas Corporation

HOLD

Current Price

$35.93

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLAY
TRS
Founded
2015
1986
Country
United States
United States
Employees
N/A
3900
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Specialties
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
2020
2007

Fundamental Metrics

Financial Performance
Metric
RLAY
TRS
Price
$8.29
$35.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
2
Target Price
$16.00
$41.50
AVG Volume (30 Days)
2.2M
608.9K
Earning Date
11-06-2025
10-28-2025
Dividend Yield
N/A
0.44%
EPS Growth
N/A
68.70
EPS
N/A
1.08
Revenue
$8,355,000.00
$1,013,740,000.00
Revenue This Year
$20.47
$11.57
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$33.46
Revenue Growth
N/A
11.83
52 Week Low
$1.78
$19.33
52 Week High
$9.04
$40.34

Technical Indicators

Market Signals
Indicator
RLAY
TRS
Relative Strength Index (RSI) 57.67 62.33
Support Level $8.13 $35.41
Resistance Level $8.76 $35.99
Average True Range (ATR) 0.48 0.71
MACD -0.01 0.25
Stochastic Oscillator 54.63 87.00

Price Performance

Historical Comparison
RLAY
TRS

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About TRS TriMas Corporation

TriMas Corp designs, develops and manufactures a diverse set of products primarily for the consumer products, aerospace & defense, and industrial markets . The company operates through three segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The aerospace segment supplies blind bolts, fasteners, rivets, and other products for the aerospace industry. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners.

Share on Social Networks: